Multicenter comparison of 18F-FDG and 68Ga-DOTA-peptide PET/CT for pulmonary carcinoid

Filippo Lococo, Alessandro Giordano, Guido Rindi, Vittoria Rufini, Germano Perotti, Chiara De Waure, Antonella Stefanelli, Pierluigi Granone, Giuseppe Cardillo, Angelina Filice, Paolo Graziano, Giulio Rossi, Giorgio Sgarbi, Annibale Versari

Research output: Contribution to journalArticle

41 Citations (Scopus)


The aims of this study were to retrospectively evaluate and compare the detection rate (DR) of 68Ga-DOTA-peptide and 18F-FDG PET/CT in the preoperative workup of patients with pulmonary carcinoid (PC) and to assess the utility of various functional indices obtained with the 2 tracers in predicting the histological characterization of PC, that is, typical versus atypical.
Original languageEnglish
Pages (from-to)e183-e183-9
Number of pages7
JournalClinical Nuclear Medicine
Publication statusPublished - 2015


  • Adult
  • Aged
  • Aged, 80 and over
  • Carcinoid Tumor
  • Female
  • Fluorodeoxyglucose F18
  • Humans
  • Lung Neoplasms
  • Male
  • Middle Aged
  • Multimodal Imaging
  • Octreotide
  • Organometallic Compounds
  • Positron-Emission Tomography
  • Retrospective Studies
  • Tomography, X-Ray Computed


Dive into the research topics of 'Multicenter comparison of 18F-FDG and 68Ga-DOTA-peptide PET/CT for pulmonary carcinoid'. Together they form a unique fingerprint.

Cite this